Skip to content

Author

E. Okorigba

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 19032: GLP-1 Receptor Agonists Added to Statin Therapy and Cardiovascular Outcomes in Patients with Atherosclerotic Cardiovascular Disease and Obesity

Background: Statins reduce cardiovascular events in atherosclerotic cardiovascular disease (ASCVD), yet residual risk remains high in patients with obesity. Whether adding a GLP-1 receptor agonist (GLP-1 RA) to statin therapy further reduces mortality, myocardial infarction (MI), and ischemic stroke in this populati...

Sunanda Tah, E. Okorigba, M. Cheshire · 0 citations
Nov 2026

One-Year Comparative Outcomes of Direct Oral Anticoagulants Versus Warfarin In Patients With Left Ventricular Thrombus And High Bleeding Risks.

Management of left ventricular (LV) thrombus in patients with high bleeding risk presents a therapeutic challenge. Warfarin has been the traditional anticoagulant used for left ventricular thrombus; direct oral anticoagulants (DOACs) are increasingly used as alternatives. We decided to study whether DOAC offered any ad...

S. Osineye, E. Okorigba, P. Olayiwola et al. · 0 citations
Nov 2026

Abstract 15549: Adult Congenital Heart Disease as a Risk Modifier After Atrial Fibrillation Ablation: A Propensity Matched Analysis

Background: Catheter ablation is increasingly used for rhythm control in adults with congenital heart disease (ACHD) and atrial fibrillation (AF). However, contemporary data comparing post-ablation outcomes between ACHD and non-ACHD populations remain limited. We evaluated cardiovascular, arrhythmic, and procedural...

E. Okorigba, Laurentia Ugoji, Ogheneakpobor E. Ubogun et al. · 0 citations
Nov 2026

Abstract 9947: Dual versus Single Antiplatelet Therapy with Clopidogrel in Spontaneous Coronary Artery Dissection: A Propensity-Matched Real-World Analysis

Background: Spontaneous coronary artery dissection (SCAD) is a non-atherosclerotic cause of acute coronary syndrome predominantly affecting women, accounting for up to 35% of acute coronary syndromes in women under 50. Consensus statements favor single antiplatelet therapy (SAPT), but prior observational studies hav...

C. Aghasili, E. Okorigba, O. Obadare et al. · 0 citations
Nov 2026

Abstract 7770: Comparative Effectiveness of Direct Oral Anticoagulants in Preventing Post-Thrombotic Syndrome After Acute Deep Vein Thrombosis

Background: Post-thrombotic syndrome (PTS) is a common chronic complication following acute deep vein thrombosis (DVT), affecting up to 20-50% of patients and leading to impaired quality of life and increased healthcare utilization. While direct oral anticoagulants (DOACs) are widely used for venous thromboembolism...

A. Abdelkhalek, I. Ogieuhi, E. Okorigba et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.